Diagnostic and management strategies for diffuse interstitial lung disease.
Patients with diffuse interstitial lung diseases (DILD) are challenging to treat. Many patients with DILD have inadequate information about the disease process, an imprecise diagnosis, unsatisfactory treatment or unacceptable side effects associated with therapy, and poorly controlled symptoms of progressive illness. Establishing an accurate diagnosis is necessary so that the patient and his/her family can be provided with reasonable expectations about prognosis and outcome from therapy. A pragmatic approach is presented that emphasizes diagnostic strategies and plans for therapy that are effective and resource efficient and that will help maintain patient satisfaction.
Reynolds
H Y
HY
Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey 17033-0850, USA.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D018893:Bronchoalveolar Lavage; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D013902:Radiography, Thoracic; D015203:Reproducibility of Results; D012129:Respiratory Function Tests; D013906:Thoracoscopy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents